MedPath

Effect of drugs on blood sugar levels in prediabetic hypertensive patients

Not Applicable
Completed
Conditions
Health Condition 1: null- PRE-DIABETICS with HYPERTENSIO
Registration Number
CTRI/2015/06/005886
Lead Sponsor
MAMATA GENERAL HOSPITA
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
70
Inclusion Criteria

• Age >= 18 years and <=75 years of either gender

• Systolic blood pressure >= 140 and/or diastolic blood pressure >= 90 mmHg,

• Patients on monotherapy of ACE-inhibitors / Angiotensin II-receptor blockers for the control of their blood pressure.

• Impaired glucose tolerance with blood glucose levels between 140 â?? 200 mg/dl in oral Glucose Tolerance Test (Oral GTT)

Exclusion Criteria

• Previous or current antidiabetic medications

• Patients with higher blood glucose levels > 200mg/dl, with overt diabetes

• Brittle pre-diabetic patients in whom the physician anticipates to initiate antidiabetic medications within next 6 months

•Hypertensive patients in whom the physician anticipates to start polytherapy within next 6 months

• Female patients who are pregnant or nursing or planning pregnancy within the duration of the study

• Suspected or known secondary cause of hypertension.

Study & Design

Study Type
Observational
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
The effect of ACE Inhibitors /ARBs on blood glucose level in hypertensive pre- diabetic patients by periodic Glucose Tolerance Test (GTT).Timepoint: 1 BASELINE <br/ ><br>2 SIX MONTHS <br/ ><br>3 TWELVE MONTHS
Secondary Outcome Measures
NameTimeMethod
The exclusive role of RAS blockade, if any, in relation to other contributing factors such as Age, Sex, BMI, Blood pressure which may have confounding effect on the outcome.Timepoint: 1 BASELINE <br/ ><br>2 SIX MONTHS <br/ ><br>3 TWELVE MONTHS
© Copyright 2025. All Rights Reserved by MedPath